Innoviva Company Profile (NASDAQ:INVA)

About Innoviva

Innoviva, Inc., formerly Theravance, Inc., focuses on bringing new medicines to patients in areas of unmet need. The Company is engaged in the development, commercialization and financial management of bio-pharmaceuticals. Its portfolio focuses on the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol (FF/VI)) and ANORO ELLIPTA (umeclidinium bromide/vilanterol (UMEC/VI)). It operates in providing capital return to stockholders by maximizing the potential value of its respiratory assets partnered with GSK segment. RELVAR/BREO is a once-a-day combination inhaled respiratory medicine consisting of VI, a LABA and FF, an inhaled corticosteroid (FF/VI) delivered via the ELLIPTA dry powder inhaler. ANORO ELLIPTA is a dual bronchodilator consisting of UMEC, a long-acting muscarinic antagonist (LAMA) and VI, a LABA for the treatment of chronic obstructive pulmonary diseases (COPD).

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: Biotechnology
Exchange: NASDAQ
Symbol: INVA
CUSIP: 88338T10

Key Metrics:

Previous Close: $11.13
50 Day Moving Average: $11.59
200 Day Moving Average: $11.79
52-Week Range: $6.36 - $14.15
Trailing P/E Ratio: 68.06
Foreward P/E Ratio: 9.68
P/E Growth: 0.25
Market Cap: $1.25B
Outstanding Shares: 111,202,000
Beta: 1.72

Profitability:

Net Margins: 20.15%
Return on Equity: -7.39%
Return on Assets: 6.31%

Debt:

Debt-to-Equity Ratio: -1.99%
Current Ratio: 13.02%
Quick Ratio: 13.02%

Additional Links:

Companies Related to Innoviva:

Consensus Ratings for Innoviva (NASDAQ:INVA) (?)

Ratings Breakdown:	2 Hold Ratings, 1 Buy Rating
Consensus Rating:	Hold (Score: 2.33)
Consensus Price Target:	$10.00 (10.15% downside)

Analysts' Ratings History for Innoviva (NASDAQ:INVA)

Show:

Date	Firm	Action	Rating	Price Target
7/31/2016	Robert W. Baird	Reiterated Rating	Neutral	$9.00 -> $11.00
10/29/2015	Cowen and Company	Lower Price Target	Market Perform	$15.00 -> $10.00
10/5/2015	Morgan Stanley	Reiterated Rating	Overweight	$7.00 -> $9.00
9/10/2015	Sanford C. Bernstein	Reiterated Rating	Market Perform	$15.00
9/9/2015	Bank of America Corp.	Downgrade	Buy -> Neutral	$16.00 -> $13.00
12/2/2014	Leerink Swann	Downgrade	Outperform -> Market Perform	$17.00

(Data available from 9/27/2014 forward)

Earnings History for Innoviva (NASDAQ:INVA)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/26/2016
7/28/2016	Q216	$0.11	$0.17	$31.13 million	$32.47 million	View	Listen
4/28/2016	Q116	$0.09	$0.04	$28.61 million	$24.17 million	View	Listen
2/3/2016	Q415	$0.01	$0.04	$20.17 million	$22.80 million	View	N/A
10/28/2015	Q315	($0.03)	($0.04)	$15.23 million	$13.56 million	View	Listen
7/29/2015	Q2	($0.06)	($0.07)	$10.90 million	$10.70 million	View	Listen
5/6/2015	Q115	($0.08)	($0.09)		$6.80 million	View	Listen
2/18/2015	Q414	($0.15)	($0.14)	$5.42 million	$7.30 million	View	N/A
10/30/2014	Q314	($0.14)	($0.19)	$6.30 million		View	N/A
8/18/2014		($0.53)	($0.18)			View	N/A
8/6/2014	Q214	($0.44)	($0.57)	$4.39 million	$0.93 million	View	N/A
5/6/2014	Q114	($0.53)	($0.62)	$4.52 million	$0.17 million	View	N/A
2/6/2014	Q413	($0.38)	($0.46)	$6.03 million	$1.60 million	View	N/A
10/24/2013	Q313	$0.69	($0.44)	$3.08 million	$0.44 million	View	N/A
7/25/2013	Q2 2013	($0.46)	($0.37)	$1.43 million	$1.33 million	View	N/A
4/25/2013	Q1 2013	($0.38)	($0.39)	$2.71 million	$1.34 million	View	N/A
2/12/2013	Q4 2012	($0.36)	($0.33)	$3.88 million	$5.80 million	View	N/A
10/30/2012		($0.39)	($0.37)			View	N/A
7/31/2012		($0.42)	($0.42)			View	N/A
4/26/2012		$1.02	$0.93			View	N/A
2/9/2012		($0.38)	($0.45)			View	N/A
10/27/2011		($0.33)	($0.37)			View	N/A
7/28/2011		($0.27)	($0.31)			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Innoviva (NASDAQ:INVA)

Current Year EPS Consensus Estimate: $0.62 EPS
Next Year EPS Consensus Estimate: $1.15 EPS

Dividend History for Innoviva (NASDAQ:INVA)

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/30/2015	quarterly	$0.25	7.01%	9/8/2015	9/10/2015	9/30/2015
5/7/2015	quarterly	$0.25	6.43%	6/10/2015	6/12/2015	6/30/2015
2/24/2015	quarterly	$0.25	5.85%	3/10/2015	3/12/2015	3/31/2015
10/31/2014	quarterly	$0.25	6.24%	11/21/2014	11/25/2014	12/23/2014
8/6/2014	quarterly	$0.25		8/26/2014	8/28/2014	9/18/2014

(Data available from 1/1/2013 forward)

Insider Trading History for Innoviva (NASDAQ:INVA)

Insider Ownership Percentage: 1.60%
Institutional Ownership Percentage: 81.20%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/22/2016	Eric Desparbes	CFO	Sell	3,700	$11.77	$43,549.00
5/18/2016	James L Tyree	Director	Sell	813	$10.47	$8,512.11
5/11/2015	Plc Glaxosmithkline	Major Shareholder	Buy	85,579	$1,369,260.00	$117,179,901,540.00
8/13/2014	Junning Lee	VP	Sell	53,424	$22.50	$1,202,040.00
8/12/2014	Bradford J Shafer	SVP	Sell	28,156	$22.13	$623,092.28
8/11/2014	Bradford J Shafer	SVP	Sell	27,108	$22.12	$599,628.96
9/12/2013	Rick Winningham	CEO	Sell	22,353	$40.03	$894,790.59
7/30/2013	Mathai Mammen	SVP	Sell	7,000	$36.51	$255,570.00
6/7/2013	Bradford J Shafer	SVP	Sell	31,038	$35.04	$1,087,571.52
5/29/2013	David L Brinkley	Insider	Sell	3,808	$35.01	$133,318.08
5/13/2013	David L Brinkley	Insider	Sell	16,129	$40.33	$650,482.57
8/7/2012	Michael W Aguiar	CFO	Sell	60,000	$27.04	$1,622,400.00

(Data available from 1/1/2013 forward)

Latest Headlines for Innoviva (NASDAQ:INVA)

Date	Headline
	Earnings Analysis & Update for Innoviva Inc (NYSE:INVA)? - Frisco Fastball (NASDAQ:INVA) friscofastball.com - September 16 at 5:29 PM
	Shares Lower Over the Past Quarter: Innoviva, Inc. (NASDAQ:INVA) - Post News (NASDAQ:INVA) www.kentuckypostnews.com - September 11 at 9:54 AM
	Innoviva Inc. (INVA): Billionaire Seth Klarman's Baupost Group Reduces Stake - Insider Monkey (blog) (NASDAQ:INVA) www.insidermonkey.com - September 11 at 9:54 AM
	Innoviva Inc. (INVA): Billionaire Seth Klarman’s Baupost Group Reduces Stake (NASDAQ:INVA) feedproxy.google.com - September 10 at 1:18 PM
	Innoviva (INVA), GlaxoSmithKline (GSK) Announce Publication of Positive Salford Lung Study Data - StreetInsider.com (NASDAQ:INVA) www.streetinsider.com - September 8 at 5:31 PM
	Stock Sliding Down Over the Last Month: Innoviva, Inc. (:INVA) - Post News (NASDAQ:INVA) www.kentuckypostnews.com - September 8 at 5:31 PM
	Innoviva to Present at Morgan Stanley Global Healthcare Conference and Rodman & Renshaw 19 th Annual Global Investment Conference (NASDAQ:INVA) www.businesswire.com - September 8 at 9:35 AM
	Stock Trading Above Moving Averages: Innoviva, Inc. (:INVA) - Post News (NASDAQ:INVA) www.kentuckypostnews.com - September 7 at 5:49 PM
	Innoviva, Inc. (NASDAQ:INVA) To Report September 2016 Results - The Voice Registrar (NASDAQ:INVA) voiceregistrar.com - September 7 at 5:49 PM
	Innoviva to Present at Morgan Stanley Global Healthcare Conference and Rodman & Renshaw 19th Annual Global Investment Conference (NASDAQ:INVA) finance.yahoo.com - September 7 at 5:49 PM
	Innoviva (INVA), GlaxoSmithKline (GSK) Announce Publication of Positive Salford Lung Study Data (NASDAQ:INVA) www.streetinsider.com - September 6 at 5:38 PM
	INNOVIVA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:INVA) biz.yahoo.com - September 6 at 5:38 PM
	Innoviva to Present at Wells Fargo and Baird Healthcare Conferences in Early September (NASDAQ:INVA) finance.yahoo.com - August 31 at 10:26 AM
	Proofpoint : Application Software Stocks Under Scanner -- Rubicon Project, Mitek Systems, Innoviva, and Proofpoint (NASDAQ:INVA) www.4-traders.com - August 29 at 10:12 AM
	INVA Crosses Above Average Analyst Target (NASDAQ:INVA) www.nasdaq.com - August 29 at 10:12 AM
	Innoviva Breaks Below 200-Day Moving Average - Notable for INVA - Nasdaq (NASDAQ:INVA) www.nasdaq.com - August 25 at 5:41 PM
	Innoviva Breaks Below 200-Day Moving Average - Notable for INVA (NASDAQ:INVA) www.nasdaq.com - August 25 at 10:41 AM
	Innoviva Becomes Oversold (INVA) (NASDAQ:INVA) www.nasdaq.com - August 24 at 5:33 PM
	Stock Gaining Over the Past Six Months: Innoviva, Inc. (:INVA) - Post News (NASDAQ:INVA) www.kentuckypostnews.com - August 22 at 10:14 AM
	Shares Holding Above Moving Averages: Innoviva, Inc. (:INVA) - Post News (NASDAQ:INVA) www.kentuckypostnews.com - August 19 at 5:40 PM
	Institutions Have Decreased Their Ownership of Innoviva, Inc. (:INVA) - Post News (NASDAQ:INVA) www.kentuckypostnews.com - August 19 at 8:38 AM
	3 Pullback Plays For A Quiet Summer Market (JCP, ADXS) (NASDAQ:INVA) www.investopedia.com - August 18 at 5:41 PM
	INNOVIVA, INC. Financials (NASDAQ:INVA) finance.yahoo.com - August 12 at 5:45 PM
	Overboarded Directors at Valeant, Yahoo! and Elsewhere Struggle With Activists, M&A (NASDAQ:INVA) www.thestreet.com - August 12 at 5:45 PM
	ETF’s with exposure to Innoviva, Inc. : August 5, 2016 (NASDAQ:INVA) www.capitalcube.com - August 5 at 5:49 PM
	INNOVIVA, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:INVA) biz.yahoo.com - August 5 at 8:41 AM
	Innoviva, Inc. :INVA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 (NASDAQ:INVA) www.capitalcube.com - August 3 at 5:59 PM
	Keryx (KERX) Stock Down on Wider Q2 Loss, Supply Issues (NASDAQ:INVA) finance.yahoo.com - August 2 at 10:29 AM
	Innoviva: Finally Starting To Gain Some Trust - Seeking Alpha (NASDAQ:INVA) seekingalpha.com - July 31 at 5:21 PM
	Edited Transcript of INVA earnings conference call or presentation 28-Jul-16 9:00pm GMT (NASDAQ:INVA) finance.yahoo.com - July 29 at 4:20 PM
	Innoviva Reports Second Quarter 2016 Financial Results - Business Wire (press release) (NASDAQ:INVA) www.businesswire.com - July 29 at 8:37 AM
	Innoviva beats 2Q profit forecasts (NASDAQ:INVA) sg.finance.yahoo.com - July 28 at 6:34 PM
	4:17 pm Innoviva reports EPS in-line, beats on revs (NASDAQ:INVA) finance.yahoo.com - July 28 at 4:17 PM
	INNOVIVA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:INVA) biz.yahoo.com - July 28 at 4:14 PM
	Innoviva Reports Second Quarter 2016 Financial Results (NASDAQ:INVA) finance.yahoo.com - July 28 at 4:05 PM
	Vertex (VRTX) Posts Narrower Q2 Loss, Revenues Fall Short - Nasdaq (NASDAQ:INVA) www.nasdaq.com - July 28 at 8:41 AM
	Amgen (AMGN) Tops Q2 Earnings & Revenues, Raises View (NASDAQ:INVA) finance.yahoo.com - July 28 at 8:02 AM
	Q2 2016 Innoviva Inc Earnings Release - After Market Close (NASDAQ:INVA) biz.yahoo.com - July 28 at 7:07 AM
	Innoviva, Inc. (NASDAQ:INVA) To Report June 2016 Results - The Voice Registrar (NASDAQ:INVA) voiceregistrar.com - July 27 at 8:28 AM
	After GILD Earnings, Which Biomed Stock is Best Right Now? (NASDAQ:INVA) finance.yahoo.com - July 26 at 4:55 PM
	Notable Monday Option Activity: CAVM, INVA, BWLD - Nasdaq (NASDAQ:INVA) www.nasdaq.com - July 26 at 8:37 AM
	Should You Buy Innoviva (INVA) Ahead of Earnings? (NASDAQ:INVA) finance.yahoo.com - July 26 at 8:36 AM
	Actelion (ALIOF) Beats Q2 Earnings & Revenues, View Up - Nasdaq (NASDAQ:INVA) www.nasdaq.com - July 24 at 5:20 PM
	Synta (SNTA) Cuts Q2 Loss Y/Y, Madrigal Merger in Focus (NASDAQ:INVA) finance.yahoo.com - July 23 at 9:40 AM
	Aegerion to Withdraw Juxtapid from EU, Reduces Workforce - Nasdaq (NASDAQ:INVA) www.nasdaq.com - July 22 at 5:36 PM
	Earnings Quick View: Centene Corporation (NYSE:CNC), Terreno Realty Corporation (NYSE:TRNO), Globant S.A. ... - Engelwood Daily (NASDAQ:INVA) www.engelwooddaily.com - July 22 at 5:36 PM
	Synta (SNTA) Cuts Q2 Loss Y/Y, Madrigal Merger in Focus - Yahoo Finance (NASDAQ:INVA) finance.yahoo.com - July 22 at 5:36 PM
	Innoviva, Inc. (NASDAQ:INVA) Upcoming Earnings: What matter for investors? - The Voice Registrar (NASDAQ:INVA) voiceregistrar.com - July 22 at 5:36 PM
	Biogen (BIIB) Stock Up on Q2 Earnings Beat, Raised Outlook (NASDAQ:INVA) finance.yahoo.com - July 21 at 11:42 AM
	Innoviva to Report Second Quarter 2016 Financial Results on July 28 at 5:00 p.m. EDT (NASDAQ:INVA) finance.yahoo.com - July 20 at 4:05 PM